Aptus Capital Advisors, LLC Alpha Tau Medical Ltd. Transaction History
Aptus Capital Advisors, LLC
- $4.95 Billion
- Q1 2024
A detailed history of Aptus Capital Advisors, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 11,945 shares of DRTS stock, worth $26,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,945Holding current value
$26,398% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DRTS
# of Institutions
30Shares Held
1.92MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY339KShares$748,6680.1% of portfolio
-
Morgan Stanley New York, NY309KShares$681,9660.0% of portfolio
-
Hoyle Cohen, LLC269KShares$594,6840.06% of portfolio
-
Corbin Capital Partners, L.P. New York, NY260KShares$574,8401.86% of portfolio
-
High Tower Advisors, LLC Chicago, IL213KShares$469,6420.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $153M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...